I+D, farmacovigilancia y asuntos reglamentarios

I+D, Farmacovigilancia y Regulatory Affairs

Investigar, desarrollar, probar y lanzar nuevas soluciones farmacológicas. El proceso de desarrollo dura de 8 a 10 años y consta de 4 fases.

  • I+D, Farmacovigilancia y Regulatory Affairs

    Investigar, desarrollar, probar y lanzar nuevas soluciones farmacológicas. El proceso de desarrollo dura de 8 a 10 años y consta de 4 fases.
Título Ubicación Sort ascending Fecha Req ID
Restablecer
Clinical Program Leader, Neonatology & Care
Clinical Program Leader, Neonatology & Care Europe, IT 19 feb 2026 6955
Europe, IT 19 feb 2026 6955
Senior Manager, CMC Regulatory Affairs, Global Rare Diseases
Senior Manager, CMC Regulatory Affairs, Global Rare Diseases Europe, IT 10 feb 2026 6592
Europe, IT 10 feb 2026 6592
Senior Director, Clinical Excellence AIR - Bronchiectasis & Non-obstructive Lung Diseases
Senior Director, Clinical Excellence AIR - Bronchiectasis & Non-obstructive Lung Diseases Europe, IT 16 feb 2026 6111
Europe, IT 16 feb 2026 6111
INTERN - Patient Engagement
INTERN - Patient Engagement PARMA, IT 27 feb 2026 5993
PARMA, IT 27 feb 2026 5993
Senior Director, Clinical Biometrics & Analytics
Senior Director, Clinical Biometrics & Analytics Parma, IT 12 feb 2026 6387
Parma, IT 12 feb 2026 6387
R&D Manufacturing & Technology Transfer Manager
R&D Manufacturing & Technology Transfer Manager Parma, IT 18 feb 2026 6501
Parma, IT 18 feb 2026 6501
Sr. Manager, CMC Regulatory Affairs
Sr. Manager, CMC Regulatory Affairs United States, US 20 feb 2026 6204
United States, US 20 feb 2026 6204